Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Clin Exp Pharmacol Physiol. 2012 Oct;39(10):858–863. doi: 10.1111/1440-1681.12001

Fig. 3.

Fig. 3

Effects of aldosterone and p21 siRNA on tumour necrosis factor (TNF)-α mRNA levels in human proximal tubular cells (A) and protein levels in the culture medium (B) at 3 and 5 days after aldosterone treatment. Data are expressed as means ± S.E.M.; n = 5 or 6 per group. *P < 0.05, **P < 0.01, compared to the same-day aldosterone-treatment group.